Citadel Advisors - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 52 filers reported holding VERRICA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$112,215
-82.0%
28,884
-73.3%
0.00%
Q2 2023$623,893
+16.2%
108,127
+31.0%
0.00%
Q1 2023$536,692
+39.2%
82,568
-41.1%
0.00%
Q4 2022$385,685
+7.7%
140,249
+14.6%
0.00%
Q3 2022$358,000
+155.7%
122,354
+68.3%
0.00%
Q2 2022$140,000
-41.7%
72,705
+145.3%
0.00%
Q1 2022$240,000
-46.7%
29,640
-17.7%
0.00%
Q3 2021$450,00036,0000.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 5,038,983$29,074,9310.84%
BML Capital Management, LLC 150,000$865,5000.78%
Avoro Capital Advisors LLC 2,954,064$17,044,9490.23%
SteelPeak Wealth, LLC 135,361$781,0330.05%
Legacy Trust 18,750$108,1880.03%
GSA CAPITAL PARTNERS LLP 38,168$2200.02%
Miracle Mile Advisors, LLC 118,221$682,1350.02%
SPC Financial, Inc. 30,000$173,1000.02%
KORNITZER CAPITAL MANAGEMENT INC /KS 129,251$745,7780.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 74,550$430,1540.01%
View complete list of VERRICA PHARMACEUTICALS INC shareholders